EPISODE · Mar 30, 2026 · 32 MIN
Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
from Biohacking News by Zestology · host Tony Wrighton
Yet more GLP1 news this week. People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle. So are a tool that biohackers have known about for years - CGMs - the answer? Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.
NOW PLAYING
Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
No transcript for this episode yet
Similar Episodes
No similar episodes found.